Global analysis of antimicrobial resistance in Campylobacter

Announcing a new article publication for Zoonoses journal. The zoonotic pathogen Campylobacter is a major foodborne bacterial species worldwide. The distribution and drivers of antimicrobial resistance (AMR) in global Campylobacter strains remain largely unknown. Therefore, a comprehensive analysis of longitudinal trends and driving factors of AMR in Campylobacter is necessary at a global level.

66,771 Campylobacter genomes (24,115 from C. coli and 42,656 from C. jejuni) in 53 countries/regions during 1954-2023 were downloaded from public repositories and a comprehensive analysis was performed.

The Campylobacter isolates were categorized into 2,771 sequence types (STs), 45 of which were shared among humans, chickens, pigs, cattle, and the environment. The spatial and temporal characteristics of resistance across antimicrobial classes on a global scale were uncovered, and observed increased trends in the aminoglycoside, tetracycline, and fluoroquinolone resistance of C. jejuni during the past 23 years. Some of the antibiotic, climate, and socioeconomic indicators collected from the World Bank might potentially have driven the rise of AMR in various countries/regions to varying degrees.

A global genetic atlas of Campylobacter is presented, which provides valuable insights for understanding the transmission dynamics of AMR in this species.

Source:
Journal references:

Jia, S., et al. (2025). Longitudinal Trends and Drivers of Antimicrobial Resistance in Campylobacter Worldwide (1954-2023). Cell Stem Cell. doi.org/10.15212/ZOONOSES-2024-0060

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can probiotics restore antibiotic-perturbed microbiota?